Skip to main content
. 2022 May 30;11(6):735. doi: 10.3390/antibiotics11060735
AChE Acetylcholinesterase
AhR Aryl Hydrocarbon Receptor
AMH Anti-Müllerian hormone
BALF Bronchoalveolar Lavage Fluid
BMI Body Mass Index
CEC Contaminants of Emerging Concern
CNS Central Nervous System
2,8-DCDD 2,8-dichlorodibenzo-p-dioxin
2,4-DCP 2,4-Dichlorophenol
EDCs Endocrine Disrupting Chemicals
EDTA Ethylenediaminetetraacetic Acid
ENR Enoyl-acyl carrier Protein Reductase
EU European Union
FASN Fatty Acid Synthase Inhibitor
FDA Food and Drug Administration
FSH Follicle-stimulating hormone
FT3 Triiodothyronine
FT4 Thyroxine
GOT Glutamic Oxaloacetic Transaminase
GPT Glutamic Pyruvic Transaminase
HCC Hepatocellular Carcinoma
HOME Health Outcomes and Measures of the Environment
HUVEC Human Umbilical Vein Endothelial Cell
IC50 Half Minimal Inhibitory Concentration
IgE Immunoglobulin E
IL-6 Interleukin-6
LU Luteinizing hormone
LPS Lipopolysaccharide
MIC Minimum Inhibitory Concentration
MTCS Methyltriclosan
NHANES National Health and Nutrition Examination Surveys
OTC Over-the-counter
PCOS Polycystic Ovary Syndrome
PPCPs Pharmaceutical and Personal Care Products
PVM/MA Polyvinylmethyl Ether Maleic Acid
REACH Registration, Evaluation, Authorisation and Restriction of Chemicals
ROS Reactive Oxygen Species
SHIME Simulator of the Human Intestinal Microbial Ecosystem
SSIs Surgical Site Infections
TCC Triclocarban
TCS Triclosan
TNF-α Tumor Necrosis Factor alpha
TP Total Protein
TSH Thyroid-stimulating hormone
UDP Uridine diphosphate
UGTs UDP-glucuronosyltransferases